ATMPsPricing16/11/2022Beyond value: Why cell and gene therapy pricing requires new thinkingWatch PresentationShare article:LinkedInEmailCopy Link WODC Europe, 2022— Adam HutchingsRelated articles From launch to legacy: Pricing excellence through forecasting & analyticsPricing05/03/2025 Gene therapy mini-series: Novel payment models to facilitate patient access to gene therapyATMPsPricing15/10/2024 Gene therapy mini-series: Facilitating effective health technology assessment for gene therapyATMPsValue/HTA15/10/2024 Gene therapy mini-series: Enhancing the delivery of gene therapy through specific care modelsATMPs15/10/2024
Gene therapy mini-series: Novel payment models to facilitate patient access to gene therapyATMPsPricing15/10/2024
Gene therapy mini-series: Facilitating effective health technology assessment for gene therapyATMPsValue/HTA15/10/2024
Gene therapy mini-series: Enhancing the delivery of gene therapy through specific care modelsATMPs15/10/2024